ZA200103065B - Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents

Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.

Info

Publication number
ZA200103065B
ZA200103065B ZA200103065A ZA200103065A ZA200103065B ZA 200103065 B ZA200103065 B ZA 200103065B ZA 200103065 A ZA200103065 A ZA 200103065A ZA 200103065 A ZA200103065 A ZA 200103065A ZA 200103065 B ZA200103065 B ZA 200103065B
Authority
ZA
South Africa
Prior art keywords
heterocycloalkylbenzocyclobutane
heteroarylbenzocyclobutane
compounds
preparation
pharmaceutical compositions
Prior art date
Application number
ZA200103065A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Aimee Dessinges
Betrand Goument
Mark Millan
Francoise Lejeune
Mauricette Brocco
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA200103065B publication Critical patent/ZA200103065B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40—Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ZA200103065A 2000-04-13 2001-04-12 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them. ZA200103065B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0004742A FR2807753B1 (fr) 2000-04-13 2000-04-13 Nouveaux derives d'heterocycloalkylbenzocyclobutane et d'heteroarylbenzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ZA200103065B true ZA200103065B (en) 2001-10-18

Family

ID=8849212

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200103065A ZA200103065B (en) 2000-04-13 2001-04-12 Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.

Country Status (25)

Country Link
US (1) US6420413B2 (hu)
EP (1) EP1146041B1 (hu)
JP (1) JP3761796B2 (hu)
KR (1) KR100456795B1 (hu)
CN (1) CN1166659C (hu)
AR (1) AR028324A1 (hu)
AT (1) ATE254102T1 (hu)
AU (1) AU777825B2 (hu)
BR (1) BR0101444A (hu)
CA (1) CA2344255C (hu)
DE (1) DE60101177T2 (hu)
DK (1) DK1146041T3 (hu)
EA (1) EA004473B1 (hu)
ES (1) ES2210104T3 (hu)
FR (1) FR2807753B1 (hu)
HK (1) HK1042477B (hu)
HU (1) HUP0101503A3 (hu)
MX (1) MXPA01003553A (hu)
NO (1) NO318158B1 (hu)
NZ (1) NZ511092A (hu)
PL (1) PL347056A1 (hu)
PT (1) PT1146041E (hu)
SI (1) SI1146041T1 (hu)
TR (1) TR200302002T4 (hu)
ZA (1) ZA200103065B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2666772B1 (en) * 2002-12-20 2017-03-01 Basf Se Synthesis of amines and intermediates for the synthesis thereof
US7803894B2 (en) * 2003-12-05 2010-09-28 3M Innovatie Properties Company Coating compositions with perfluoropolyetherisocyanate derived silane and alkoxysilanes
CN105541662B (zh) * 2015-12-28 2018-04-17 云南大学 二氢萘类化合物的固相合成方法
CN107445835B (zh) * 2017-07-05 2020-09-22 江苏师范大学 一种1,2-二氢环丁烯并[a]萘衍生物及其前体的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE392893T1 (de) * 1993-06-28 2008-05-15 Wyeth Corp Neue behandlungsmethoden durch verwendung von phenethylaminderivaten
US5530013A (en) * 1994-02-14 1996-06-25 American Home Products Corporation Venlafaxine in the inducement of cognition enhancement
EP0757687A1 (en) * 1994-04-23 1997-02-12 Smithkline Beecham Plc Tricyclic derivatives as 5ht 2c? and 5ht 2b? antagonists
US5506270A (en) * 1995-01-30 1996-04-09 American Home Products Corporation Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women
FR2775687B1 (fr) * 1998-03-04 2000-04-14 Adir Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO20011862D0 (no) 2001-04-11
DE60101177T2 (de) 2004-07-29
US6420413B2 (en) 2002-07-16
NZ511092A (en) 2002-10-25
FR2807753A1 (fr) 2001-10-19
HK1042477B (zh) 2005-05-06
EP1146041A1 (fr) 2001-10-17
EP1146041B1 (fr) 2003-11-12
AU3518701A (en) 2001-10-18
CA2344255A1 (fr) 2001-10-13
EA200100343A2 (ru) 2001-10-22
HUP0101503A2 (hu) 2002-05-29
BR0101444A (pt) 2001-12-04
EA004473B1 (ru) 2004-04-29
TR200302002T4 (tr) 2004-01-21
SI1146041T1 (en) 2004-02-29
PL347056A1 (en) 2001-10-22
US20020019380A1 (en) 2002-02-14
NO318158B1 (no) 2005-02-07
CN1323794A (zh) 2001-11-28
HUP0101503A3 (en) 2003-02-28
NO20011862L (no) 2001-10-15
PT1146041E (pt) 2004-03-31
CN1166659C (zh) 2004-09-15
AU777825B2 (en) 2004-11-04
FR2807753B1 (fr) 2002-06-07
EA200100343A3 (ru) 2002-02-28
HU0101503D0 (en) 2001-06-28
ATE254102T1 (de) 2003-11-15
ES2210104T3 (es) 2004-07-01
CA2344255C (fr) 2006-07-11
JP2001302599A (ja) 2001-10-31
KR100456795B1 (ko) 2004-11-10
JP3761796B2 (ja) 2006-03-29
HK1042477A1 (en) 2002-08-16
DE60101177D1 (de) 2003-12-18
MXPA01003553A (es) 2002-06-04
AR028324A1 (es) 2003-05-07
KR20010098547A (ko) 2001-11-08
DK1146041T3 (da) 2004-03-22

Similar Documents

Publication Publication Date Title
ZA200105394B (en) Diphenylurea compounds, a process for their preparation and pharmaceutical composition containing them.
ZA200003702B (en) Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200100864B (en) Piperidine-4-sulphonamides compounds, a process for their preparation and pharmaceutical compositions containing them.
PL359373A1 (en) New substituted phthalides, a process for their preparation and pharmaceutical compositions containing them
ZA200108404B (en) Cyclobutenedione compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200100565B (en) Benzenesulfonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
ZA200110517B (en) Metalloprotease inhibitors, a process for their preparation and pharmaceutical compositions containing them.
ZA200202220B (en) Indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200202030B (en) Isoindoloindolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200110314B (en) Bicyclic amino-pyrazinones compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200106203B (en) Benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them.
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them
ZA200205598B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200205666B (en) N-benzylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200103065B (en) Heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compounds, a process for their preparation and pharmaceutical compositions containing them.
HK1053646A1 (en) BenzoÄBÜpyranoÄ3,2-HÜacridin-7-one compounds, a process for their preparation and pharmaceutical compositions containing them
ZA200103064B (en) Cyclobutaindolecarboxamide compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204757B (en) Indenoidolone compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200203086B (en) Pyrimidin-4-one compounds, a process for their preparation and pharmaceutical compositions containing them.
HK1048471A1 (en) Cycloheptene compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200101338B (en) 6-sulphamoyl-3-quinolylphosphonic acid compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200204865B (en) Cyclic α-amino-y-hydroxyaminde compounds, a process for their preparation and pharmaceutical compositions containing them.
ZA200205597B (en) Benzenesulphonamide compounds, a process for their preparation and pharmaceutical compositions containing them.